<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Long-Term Methadone Intake and Genotoxicity in Addicted Patients</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Kowsar Medical Institute</publisher>
				<availability status="unknown"><p>Copyright Kowsar Medical Institute</p>
				</availability>
				<date type="published" when="2015-02-25">2015 February 25</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mohsen</forename><surname>Rezaei</surname></persName>
							<email>rezaei.mohsen@gmail.com</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Pharmacology and Toxicology School of Pharmacy</orgName>
								<orgName type="institution">Jundishapur University of Medical Sciences</orgName>
								<address>
									<settlement>Ahvaz</settlement>
									<region>IR</region>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Cellular and Molecular Research Center</orgName>
								<orgName type="institution">Jundishapur University of Medical Sciences</orgName>
								<address>
									<settlement>Ahvaz</settlement>
									<region>IR</region>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Forouzan</forename><surname>Khodaei</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pharmacology and Toxicology School of Pharmacy</orgName>
								<orgName type="institution">Jundishapur University of Medical Sciences</orgName>
								<address>
									<settlement>Ahvaz</settlement>
									<region>IR</region>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mehdi</forename><surname>Sayah Bargard</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mahsa</forename><surname>Abasinia</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pharmacology and Toxicology School of Pharmacy</orgName>
								<orgName type="institution">Jundishapur University of Medical Sciences</orgName>
								<address>
									<settlement>Ahvaz</settlement>
									<region>IR</region>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">Department of Pharmacology and Toxicology School of Pharmacy, Jundishapur University of Medical Sciences</orgName>
								<address>
									<postBox>P.O.Box</postBox>
									<postCode>61357-33184</postCode>
									<settlement>Ahvaz</settlement>
									<region>IR</region>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Long-Term Methadone Intake and Genotoxicity in Addicted Patients</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Jundishapur Journal of Natural Pharmaceutical Products</title>
						<title level="j" type="abbrev">Jundishapur J Nat Pharm Prod</title>
						<idno type="ISSN">1735-7780</idno>
						<idno type="eISSN">2228-7876</idno>
						<imprint>
							<publisher>Kowsar Medical Institute</publisher>
							<biblScope unit="volume">10</biblScope>
							<biblScope unit="issue">1</biblScope>
							<date type="published" when="2015-02-25">2015 February 25</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.17795/jjnpp-17008</idno>
					<ptr type="open-access" target="http://europepmc.org/articles/pmc4386318?pdf=render" />
					<note type="submission">Received: January 6, 2014; Revised: August 10, 2014; Accepted: October 6, 2014</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T23:46+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Methadone</term>
					<term>Comet Assay</term>
					<term>Mutagens</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Background: It is well known that contact with some physical, chemical or biological compounds can increase the incidence of mutation. Among these compounds, are pharmaceuticals that meet long duration of use and potentially could be misused and taken more than the ordered dosage. Objectives: The aim of this study was to evaluate mutagenic effect of methadone in addicted patients referred to Imam Khomeini Hospital in Ahvaz by single cell gel electrophoresis technic or comet assay. Patients and Methods: In this study, 90 subjects were divided into dichromate treated group, no treated healthy volunteers group and test group. Each group included 30 subjects. Screening was performed according to questionnaire and qualified subjects were entered the study. Blood samples were collected and lymphocytes were isolated, mixed with low melting point agarose for slide preparation according to standard method. Slides were analyzed using fluorescence microscope and comet patterns were assessed. Results: The mutagenicity index in addicted group was robustly higher than healthy volunteers. Fortunately, this significant difference was lower than positive control. Conclusions: Genome instability in addicted patients was demonstrated in this study. Controversially, considering incoherent results of previous studies and our data, more studies in longer duration of methadone use are needed to elucidate the consequence.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Background</head><p>Control of pain in a successful treatment is an important point and requires careful consideration of appropriate dosage, type of medication and cognitive disease <ref type="bibr" target="#b0">(1)</ref>. Using opioids to control pain in acute conditions is different with chronic conditions. In these cases, other factors must be considered, particularly the rate of tolerance and physical dependence <ref type="bibr" target="#b1">(2)</ref>.</p><p>Methadone hydrochloride (synthetic derivative of diphenyl heptane) is an opioid analgesic used for moderate to light pain and detoxification and maintenance treatment of addiction to opioid <ref type="bibr" target="#b2">(3)</ref>. Methadone is similar to morphine, but its effect is somewhat longer than morphine. At least its potency and efficiency is equal to morphine. Methadone is effective via orally consumption and drug tolerance and physical dependence is slower than morphine. Symptoms of drug withdrawal after abrupt discontinuation of methadone are milder but longer than morphine. These characteristics made methadone as a medication for detoxification and maintenance treatment of chronic addiction to heroin <ref type="bibr" target="#b4">(4)</ref>. Methadone is a part of admitted program of FDA to detoxification, which acts through binding to opioid receptors in CNS and inhibition of pain pathway and general CNS depression <ref type="bibr" target="#b2">(3)</ref>. Methadone clearance is increased in pregnant women and its half-life is decreased in the third trimester of pregnancy. Therefore, to achieve an effective result, its dosage should be increased and frequency of dosages should be reduced. Detoxification by methadone is performed long-term and short-term and alcohol, benzodiazepines and medications for HIV or hepatitis can be used concomitantly <ref type="bibr" target="#b5">(5)</ref>.</p><p>With chronic exposure to some physical, chemical or biological conditions, mutation probability can be increased by several times. These include medicines that can damage the DNA of cells <ref type="bibr" target="#b6">(6)</ref>. Using some compounds in a long-term <ref type="bibr" target="#b7">(7)</ref> or simultaneous usage of some medications may produce metabolites able to cause mutation. Results regarding methadone genotoxicity are controversial and need a comprehensive evaluation to obtain unequivocal conclusions. Brambilla and colleagues in 2009 studied the effects of genetic toxicity and carcinogenicity of 120 analgesics, anti-inflammatory and anti-pyretic. Due to long-term use of methadone and higher risk of side effects, it was selected for evaluation and finally positive results were demonstrated in three assays as below: 1) Gene mutation, mouse lymphoma L5178Y cell, Tk locus 2) Chromosomal aberrations, mammalian spermatogonia in vivo</p><p>3) Dominant lethal test, mice (7).</p><p>Gorazd et al. studied genetic toxicity of methadone in 23 patients recovering methadone maintenance therapy. Lymphocytes of two control groups were exposed to known mutagenic agents. Higher proportion of cells with elevated numbers of chromatid exchanges demonstrated methadone genotoxicity <ref type="bibr" target="#b8">(8)</ref>. In another study, Skowronska et al. evaluated genotoxic effect of methadone on peripheral blood lymphocytes of 12 addict patients; sampling was performed during and at beginning of maintenance therapy <ref type="bibr" target="#b10">(9)</ref>. Surprisingly, DNA breaks and damages were reported to be reduced in methadone treated groups. Same results were reported by Zimmering et al. and Badr et al., using drosophila melanogaster and dominant lethal mutation consecutively <ref type="bibr" target="#b12">(10,</ref><ref type="bibr" target="#b13">11)</ref>.</p><p>Apoptotic effects of methadone may directly or indirectly contribute to its proposed DNA toxic effects. In this regard, Friesen and colleagues found that methadone is a potent inducer of programmed cell death in leukemic cells and Non-leukemic lymphocytes. Methadone treatment resides and resistance to chemotherapy decreased (12).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Objectives</head><p>Given controversial results regarding methadone genotoxicity, we investigated the effect of methadone genotoxicity. Altogether, research on mutagenesis of methadone may uncover its potential adverse effects contributing to overall health of patients. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Patients and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HEPES</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.">Patients and Healthy Subjects</head><p>This study was performed to evaluate mutagenic effect of methadone in addicted patients referred to Imam Khomeini Hospital in Ahvaz. Total samples of 90 subjects were divided into dichromate treated group, no treated healthy volunteers group and test group. Each group included 30 subjects as follows: No treated healthy volunteers group: normal subjects without any history of opioid consumption in the last six months. All individuals filled a detailed questionnaire according to the published protocol by the International Commission for Protection against Environmental Mutagens and Carcinogens.</p><p>Dichromate treated group: 500 μM of dichromate was added to samples as a positive agent for induction of DNA breakage <ref type="bibr" target="#b15">(13)</ref>.</p><p>Test group: all 30 subjects in this group met the inclusion criteria.</p><p>Inclusion criteria were methadone use 60 to 120 mg daily, age of 18 to 65 years, minimum period of three years for methadone consumption and IQ above 75 <ref type="bibr" target="#b12">(10,</ref><ref type="bibr" target="#b13">11)</ref>. Consents were obtained from all subjects participated in this study according to university Ethics Committee.</p><p>Exclusion criteria were use of any medicines such as benzodiazepines, amphetamine derivatives, antipsychotics, mood stabilizers, use of substances such as marijuana, crack, opiates, tramadol, mental disorders (personality disorders, mood disorders, anxiety disorders, psychoses), organic disease and positive results for HIV Ab , HCV Ab or HBS Ag (7, 10, 11).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.">Isolation of Peripheral Blood Lymphocytes</head><p>Two milliliters of peripheral blood were collected from each patient in heparinized tubes. Whole blood with Hank's solution was diluted to a ratio of 1 to 2.5 mL of sterile Ficoll solution (in the dark and temperature of 2-8°C), added to a centrifuge tube and diluted blood poured slowly to form a layer on top of the tube. The tubes were centrifuged for 20 minutes 1000 rpm (at this stage centrifugal brake or stopping using hand was avoided). After centrifugation, mononuclear cells (including lymphocytes) settle as a white layer between Ficoll and plasma. Lymphocytes were collected using pipette and transferred to another tube. The tube was filled with Hank's solution and centrifuged at 440 rpm for 10 minutes. The supernatant discarded, deposited again on Hank's solution added and mixed gently and centrifuged again for 15 minutes at 230 rpm. Besides, washing repeated with 110 rpm again. At this point, fully isolated lymphocytes achieved <ref type="bibr" target="#b16">(14)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.">Comet Assay</head><p>Afterwards, 100 µL of cell suspension premixed with low melting point agarose (LMA 1%) poured on a slide coated with normal melting point agarose (NMA 1%) and covered with cover slips. Slides were kept for 15 to 20 minutes horizontally in the ice tray to solidify. Next, the cover slips were removed from the slides and placed in a lysis solution (14.61 g NaCl, 3.72 g EDTA, 0.125 g Tris ,0.9 g NaOH , 1 g sodium lauryl sarcosinate %1, DMSO 10% , Triton x-100 1% and pH = 10) for one hour and then washed by deionized water, kept for 20 minutes in electrophoresis buffer (NaOH 12 g, EDTA 372.0 g, dH 2 O to 1000 mL and pH = 13) and electrophoresed at 25 V and 300 mA for 20 minutes and then washed with neutralized buffer (Tris 1.12 g, dH 2 O to 250 mL and pH = 7.5) for five minutes three times. Slides were immersed in ethidium bromide solution for five minutes and according to the method described by <ref type="bibr">Speit and Hartmann (15)</ref>, which is based on the original work of Singh et al. <ref type="bibr" target="#b18">(16)</ref>, slides were analyzed by fluorescence microscope. The extent and distribution of DNA damage indicated by comet assay was evaluated by examining cells. The cells were visually scored into comet classes according to tail size class (17-19): 0 = no tail, 1 = tail shorter than the diameter of the head (nucleus), 2 = tail length 1 to 2x the diameter of the head and score 3 = tail longer than 2x the diameter of the head. Comet with-out head and those with nearly all the DNA in the tail or with a very wide tail were excluded from the evaluation, because they probably represented dead cells <ref type="bibr" target="#b22">(20,</ref><ref type="bibr" target="#b23">21)</ref>. Tail length and the mutagenic index were calculated according the following formula MI = (0 NMC+ 1 SMC+ 2 MMC+ 3 LMC)/200, or we could express it as NMC = No migration cells (score 0), SMC = Short migration cells (score 1) MMC = Medium migration cells (score 2), LMC = Long migration cells (score 3) (22).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4.">Statistical Analysis</head><p>Using SPSS software, Chi-square was performed to compare the groups.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Results</head><p>Peripheral blood was collected from 30 addicted patients screened to be exclusively on methadone and lymphocytes were separated to assess the genotoxicity by the comet assay. Percent of mutagenicity index (MI) was significantly lower in the test group compared to positive control and conversely, it was higher compared to the negative control group. Addicted patients showed more than two fold MI% compared to negative control or normal samples. Damaged cells in the test group were significantly higher compared to negative control. Altogether, instability of genome was demonstrated for addicted patients according to scores obtained for damaged cells.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Discussion</head><p>Brambilla et al. studied the carcinogenic effects of 120 different drugs including analgesics, anti-inflammatory and antipyretics. Methadone, because of its predominant and long-term use for treating severe pain, and its possible side effects was investigated. Results were deemed positive in the following three areas: gene mutation, chromosomal aberrations and dominant lethal test in mice (7).</p><p>Gorazd and Kamenczak studied genetic toxicity of methadone in lymphocytes cultures of 34 patients treated with methadone. Micronuclei occurrences along with number of chromatids' changes taking place in the metaphase indicate genetic mutation. Two control groups with elements of genetic mutation were used. Increased ratio of number of cells to immense chromatid changes are indicators of genetic toxicity of methadone, although these changes are not so apparent in other groups facing mutagen <ref type="bibr" target="#b8">(8)</ref>. As indicated by these studies, genetic mutation in patients treated with methadone is controversial and therefore in this study we investigated its possible genotoxic effect. Lowest concentration of sodium dichromate, which causes a break in DNA strand is 50 µM, correlating to the dosage can increase to its maximum amount of 500 µM. higher concentrations of dichromate would cause the curve of DNA strand breaks vs. dichromate concentrations to turn into plateau. The reason for this phenomenon could be cross binding of DNA-DNA and protein-DNA, which would prevent DNA migration or could be satura-tion of activation paths to dichromate (like decrease in GSH) or even modifications in improved mechanism of DNA. Therefore, sodium dichromate in 500 µM concentration can be used as a positive control for comparison or revealing other unknown mutating agents <ref type="bibr" target="#b15">(13)</ref>.</p><p>Hodges et al. studied sodium dichromate's abilities in breaking DNA chains in three different kinds of cells: human blood cells, separated lymphocyte and cultures of A549 cells of lung's epithelial tissue. In the experiment using comet assay, increasing concentrations (10 µM, 50 and 500) had a correlating effect in breaking the number of DNA strands <ref type="bibr" target="#b25">(23)</ref>. Percentages of healthy and mutated cells (in pattern of comet) for the experimental group were determined and compared to percentage of health and mutated cells in the control groups <ref type="figure" target="#fig_0">(Figure 1)</ref>. <ref type="figure">Figure  2</ref> demonstrated the rate of mutation of experimental group and control groups, rate of mutation of experimental group compared to control group is deemed negative. There is a significant difference between the two groups. This can be an indication of instability of genome in patients participating in the experiment, compared to control group regarding scores in the experiment. <ref type="figure">Figure 2</ref> compares percentage of comet mass patterns between the experimental and control groups. In the control groups, zero scores were most prevalent and score ones were next in the numbers. In the experimental groups, scores of 1 and 3 reduced respectively. There are no 2 and 3 scores in the negative control groups. Although, there were 2 and 3 scores in the experimental group, and there was a significant statistical difference with these scores in the negative control group, this difference could indicate instability in the genome of experimental group compared to the negative control group.</p><p>In <ref type="figure">Figure 3</ref>, percentage of comet mass patterns between the experimental and control groups were compared. Zero scores in the experimental group were less compared to negative control group, which showed a meaningful difference. On the other hand, scores of 1, 2 and 3 in the experimental group increased compared to negative control group and the two had a meaningful difference regarding 1, 2 and 3 scores with each other. Increased 2 and 3 scores indicates instability in genome of experimental group compared to negative control group.</p><p>In <ref type="figure" target="#fig_0">Figure 1</ref>, percentage of mutated cells in the experimental group and control groups were compared. Mutated cells are sum of cells with 2 and 3 for a score. Percentage of experimental groups' mutated cells increased compared to control group, and showed a significant difference. This difference could be an indication of less stability of genome of experimental group patients compared to negative control group. Perez-Alvarez and Cuenca-Lopez observed that high concentrations of methadone are needed to induce death in SH-SY5Y cells. Methadone leads to a kind of cellular death and has greater similarity to necrosis than apoptosis. Cell cultures show a change in outer mitochondria membrane potential and it has been compromised and penetrable. No engagement was observed by controlling proteins of apoptosis such as BCL-XL and p53 in this process. This study showed that a reduction in cell energy level would result in cell necrosis <ref type="bibr" target="#b26">(24)</ref>.  Garcia-Fuster et al. studied external and internal apoptosis pathways in prefrontal cortex of persons using methadone and heroin. Their findings showed that in such individuals these pathways were not activated in an abnormal manner. Instead, slowing or continuous manipulation of some parts of these pathways (downregulation cytochrome C and upregulation BCL-21) induces anti apoptosis activity <ref type="bibr" target="#b27">(25)</ref>.</p><p>Friesen et al. indicated methadone as a strong inducer of death in leukemia cells. Methadone controls the proliferation of leukemia cells and induces apoptosis in them. Contrary to leukemia cells, non-leukemic lymphomas after treatment with methadone remain healthy and alive. The study showed that methadone kills leukemia cells and eliminates resistance to chemotherapy and apoptosis <ref type="bibr" target="#b14">(12)</ref>.</p><p>There was a significant difference between mutation indicators of the experimental and negative control groups (P &lt; 0.0001). Individuals who used methadone during this study had a less stable lymphoma genome compared to healthy individuals. Although on this subject and the reasons for instability of genome, study showed conflicting results, but continuous manipulation of immune system via methadone can induce or modify cellular death. Proving genotoxic effects of methadone requires further studies for a longer time of usage. To get more conclusive findings from this and previous studies, it is necessary to:</p><p>-Perform an extensive review of methadone usage periods and its effects on genome and cellular deaths.</p><p>-Conduct studies reviewing methadone usage and its relation to autoimmune diseases and allergies.</p><p>-More detailed review of reasons for instability of genome by methadone as means of new clinical targets.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors' Contributions</head><p>Study concept and design: Mohsen Rezaei. Analysis and interpretation of data: Mohsen Rezaei. Sample collection: Mehdi Sayah Bargard. Practical work: Mahsa Abasinia. Drafting of the manuscript: Forouzan Khodaei and Mohsen Rezaei. Critical revision of the manuscript for important intellectual content: Mohsen Rezaei. Statistical analysis: Mohsen Rezaei.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding/Support</head></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Percentages of Healthy and Mutated Cells (in Pattern of Comet) for the Experimental Group Were Determined and Compared to Percentage of Health and Mutated Cells in the Control Groups</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .Figure 3 .</head><label>23</label><figDesc>The Rate of Mutation in Experimental and Control Groups Comparing the Percentage of Comet Mass Patterns Between the Experimental and Control Groups</figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Jundishapur J Nat Pharm Prod. 2015;10(1):e17008</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>This work was supported by a grant (NO. 768) from the Deputy of Research, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Cognitive impairment and pain management: Review of issues and challenges</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martha</forename><forename type="middle">D</forename><surname>Buffum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Evelyn</forename><surname>Hutt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Victor</forename><forename type="middle">T</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">H</forename><surname>Craine</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">Lynn</forename><surname>Snow</surname></persName>
		</author>
		<idno type="DOI">10.1682/jrrd.2006.06.0064</idno>
		<ptr type="open-access" target="https://doi.org/10.1682/jrrd.2006.06.0064" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Rehabilitation Research and Development</title>
		<title level="j" type="abbrev">JRRD</title>
		<idno type="ISSN">0748-7711</idno>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">315</biblScope>
			<date type="published" when="2007" />
			<publisher>Journal of Rehabilitation Research &amp; Development</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Acute pain management in patients receiving opioids for chronic and cancer pain</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicola</forename><forename type="middle">L</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">E</forename><surname>Williams</surname></persName>
		</author>
		<idno type="DOI">10.1093/bjaceaccp/mki034</idno>
	</analytic>
	<monogr>
		<title level="j">Continuing Education in Anaesthesia Critical Care &amp; Pain</title>
		<title level="j" type="abbrev">Continuing Education in Anaesthesia Critical Care &amp; Pain</title>
		<idno type="ISSN">1743-1816</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="127" to="129" />
			<date type="published" when="2005-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Drug Information Handbook</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Lacy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Armstrong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">P</forename><surname>Goldman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Lance</surname></persName>
		</author>
		<editor>Lexi-comp</editor>
		<imprint>
			<date type="published" when="2009" />
			<biblScope unit="volume">18</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Jundishapur J Nat Pharm Prod</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">17008</biblScope>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title level="m" type="main">Basic and clinical pharmacology</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Katzung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Masters</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Trevor</forename><forename type="middle">A</forename></persName>
		</author>
		<editor>Twelfths ed. McGraw-Hill</editor>
		<imprint>
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Depression in methadone maintenance treatment patients: Rate and risk factors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Einat</forename><surname>Peles</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shaul</forename><surname>Schreiber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yosef</forename><surname>Naumovsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Miriam</forename><surname>Adelson</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jad.2006.09.017</idno>
		<idno type="PMID">17055063</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Affective Disorders</title>
		<title level="j" type="abbrev">Journal of Affective Disorders</title>
		<idno type="ISSN">0165-0327</idno>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">1-3</biblScope>
			<biblScope unit="page" from="213" to="220" />
			<date type="published" when="2007-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">DNA Chemical Damage and Its Detected</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shao</forename><surname>Jun</surname></persName>
		</author>
		<idno type="DOI">10.5539/ijc.v2n2p261</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/2c72/98886ee042711f07667896bb58f21a9b7bd4.pdf" />
	</analytic>
	<monogr>
		<title level="j">International Journal of Chemistry</title>
		<title level="j" type="abbrev">IJC</title>
		<idno type="ISSN">1916-9698</idno>
		<idno type="ISSNe">1916-9701</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="261" to="265" />
			<date type="published" when="2010-07-25" />
			<publisher>Canadian Center of Science and Education</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyretics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><surname>Brambilla</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonietta</forename><surname>Martelli</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.phrs.2009.03.007</idno>
		<idno type="PMID">19427580</idno>
	</analytic>
	<monogr>
		<title level="j">Pharmacological Research</title>
		<title level="j" type="abbrev">Pharmacological Research</title>
		<idno type="ISSN">1043-6618</idno>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="17" />
			<date type="published" when="2009-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Gorazd</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Kamenczak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Pach</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Schmager</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Wronka</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>Preliminary research on opioid mutagenicity</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Przegl Lek</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="245" to="253" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Skowronska</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Groszek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Schmager</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>Micronuclei as markers of DNA damage in patients addicted to opioid drugs</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Przegl Lek</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="241" to="244" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Evidence for the absence of a mutagenic effect of methadone in germ cells of Drosophila melanogaster</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Zimmering</surname></persName>
		</author>
		<idno type="DOI">10.1016/0165-1218(79)90057-0</idno>
		<idno type="PMID">107447</idno>
		<idno type="PII">0165-1218(79)90057-0</idno>
		<idno type="ark">ark:/67375/6H6-S6DQ54H7-P</idno>
		<idno type="istexId">27A10850C84457708941C06D19359320634C10E5</idno>
	</analytic>
	<monogr>
		<title level="j">Mutation Research/Genetic Toxicology</title>
		<title level="j" type="abbrev">Mutation Research/Genetic Toxicology</title>
		<idno type="ISSN">0165-1218</idno>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="133" to="134" />
			<date type="published" when="1979-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">On the mutagenicity of methadone hydrochloride. Induced dominant lethal mutation and spermatocyte chromosomal aberrations in treated males</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">M</forename><surname>Badr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>Rabouh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">S</forename><surname>Badr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mutat Res</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="235" to="284" />
			<date type="published" when="1979" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Methadone, Commonly Used as Maintenance Medication for Outpatient Treatment of Opioid Dependence, Kills Leukemia Cells and Overcomes Chemoresistance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Friesen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Roscher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Alt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Miltner</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.can-08-1227</idno>
		<idno type="PMID">18676827</idno>
		<ptr type="open-access" target="https://cancerres.aacrjournals.org/content/canres/68/15/6059.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<title level="j" type="abbrev">Cancer Research</title>
		<idno type="ISSN">0008-5472</idno>
		<idno type="ISSNe">1538-7445</idno>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="6059" to="6064" />
			<date type="published" when="2008-08-01" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Genotoxicity of chromium in human gastric mucosa cells and peripheral blood lymphocytes evaluated by the single cell gel electrophoresis (comet assay)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Trzeciak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Kowalik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Malecka-Panas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Drzewoski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Wojewodzka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Iwanenko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Sci Monit</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="24" to="33" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">An &lt;em&gt;In vitro&lt;/em&gt; Co-infection Model to Study &lt;em&gt;Plasmodium falciparum&lt;/em&gt;-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guadalupe</forename><surname>Andreani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dominic</forename><surname>Gagnon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><surname>Lodge</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michel</forename><forename type="middle">J</forename><surname>Tremblay</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dave</forename><surname>Richard</surname></persName>
		</author>
		<idno type="DOI">10.3791/4166</idno>
		<idno type="PMID">22929299</idno>
		<idno type="PMCID">PMC3487290</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3487290?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Journal of Visualized Experiments</title>
		<title level="j" type="abbrev">JoVE</title>
		<idno type="ISSNe">1940-087X</idno>
		<imprint>
			<biblScope unit="issue">66</biblScope>
			<biblScope unit="page">2012</biblScope>
			<date type="published" when="2012-08-15" />
			<publisher>MyJove Corporation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">The Comet Assay (Single-Cell Gel Test): A Sensitive Genotoxicity Test for the Detection of DNA Damage and Repair</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Günter</forename><surname>Speit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andreas</forename><surname>Hartmann</surname></persName>
		</author>
		<idno type="DOI">10.1385/1-59259-675-4:203</idno>
		<idno type="PMID">10443422</idno>
	</analytic>
	<monogr>
		<title level="m">DNA Repair Protocols</title>
		<imprint>
			<publisher>Humana Press</publisher>
			<date>1999</date>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="203" to="212" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">A simple technique for quantitation of low levels of DNA damage in individual cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Narendra</forename><forename type="middle">P</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">T</forename><surname>Mccoy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Raymond</forename><forename type="middle">R</forename><surname>Tice</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edward</forename><forename type="middle">L</forename><surname>Schneider</surname></persName>
		</author>
		<idno type="DOI">10.1016/0014-4827(88)90265-0</idno>
		<idno type="PMID">3345800</idno>
		<idno type="PII">0014-4827(88)90265-0</idno>
		<idno type="ark">ark:/67375/6H6-DJN6B0HF-G</idno>
		<idno type="istexId">A71BAA8108EB7EC5A698BF0F339BDD26004FE891</idno>
		<ptr type="open-access" target="https://zenodo.org/record/1253874/files/article.pdf" />
	</analytic>
	<monogr>
		<title level="j">Experimental Cell Research</title>
		<title level="j" type="abbrev">Experimental Cell Research</title>
		<idno type="ISSN">0014-4827</idno>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="184" to="191" />
			<date type="published" when="1988-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Mutagenicity assessment of two herbal medicines, Urtan and Carmint in human leukocytes by single cell gel electrophoresis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Jalili</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Hatami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kalantari</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Kalantar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Saudi Pharm</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">129</biblScope>
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Clastogenicity of Piper cubeba (Piperaceae) seed extract in an in vivo mammalian cell system</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Adriana</forename><forename type="middle">Pereira Freire</forename><surname>Junqueira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fabio</forename><forename type="middle">Ferreira</forename><surname>Perazzo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gustavo</forename><forename type="middle">Henrique Bianco</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edson</forename><forename type="middle">Luis</forename><surname>Maistro</surname></persName>
		</author>
		<idno type="DOI">10.1590/s1415-47572007000400025</idno>
		<ptr type="open-access" target="http://www.scielo.br/pdf/gmb/v30n3/25.pdf" />
	</analytic>
	<monogr>
		<title level="j">Genetics and Molecular Biology</title>
		<title level="j" type="abbrev">Genet. Mol. Biol.</title>
		<idno type="ISSNe">1415-4757</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="656" to="663" />
			<date type="published" when="2007" />
			<publisher>FapUNIFESP (SciELO)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">In Vitro Evaluation of Mutagenic Effect of Vitagnus and Shirafza in Human Leukocytes by Single Cell Gel Electrophoresis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kalantari</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Jalali</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Moein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Jundishapur J Nat Pharm Prod</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="26" to="31" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andreas</forename><surname>Hartmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Günter</forename><surname>Speit</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0378-4274(96)03847-7</idno>
		<idno type="PMID">9067486</idno>
		<idno type="PII">S0378-4274(96)03847-7</idno>
		<idno type="ark">ark:/67375/6H6-CMXN6R6W-N</idno>
		<idno type="istexId">6555DCF950A2C5AD57A08165F0D837C8AE933BF6</idno>
	</analytic>
	<monogr>
		<title level="j">Toxicology Letters</title>
		<title level="j" type="abbrev">Toxicology Letters</title>
		<idno type="ISSN">0378-4274</idno>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">2-3</biblScope>
			<biblScope unit="page" from="183" to="188" />
			<date type="published" when="1997-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>comet assay</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Genotoxicity determinations of coriander drop and extract of Coriander Sativum cultured fibroblast of rat embryo by comet assay</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Heibatullah</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Marzieh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Arefeh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Ebrahim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Saudi Pharm J</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="85" to="93" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">A comparison between manual microscopic analysis and computerized image analysis in the single cell gel electrophoresis assay</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kobayashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">MM Commun</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="103" to="118" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Induction of DNA-strand breaks in human peripheral blood lymphocytes and A549 lung cells by sodium dichromate: association with 8-oxo-2-deoxyguanosine formation and inter-individual variability</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">J</forename><surname>Hodges</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Adam</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">J</forename><surname>Cross</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">K</forename><surname>Chipman</surname></persName>
		</author>
		<idno type="DOI">10.1093/mutage/16.6.467</idno>
		<idno type="PMID">11682636</idno>
		<idno type="PII">1464-3804</idno>
		<idno type="ark">ark:/67375/HXZ-JP2DW2XW-C</idno>
		<idno type="istexId">09126E1FFF3A2FC0F30E7EC324D22F7EF5D58DD7</idno>
		<ptr type="open-access" target="https://academic.oup.com/mutage/article-pdf/16/6/467/9894951/160467.pdf" />
	</analytic>
	<monogr>
		<title level="j">Mutagenesis</title>
		<idno type="ISSNe">1464-3804</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="467" to="474" />
			<date type="published" when="2001-11-01" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Methadone induces necrotic-like cell death in SH-SY5Y cells by an impairment of mitochondrial ATP synthesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sergio</forename><surname>Perez-Alvarez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><forename type="middle">D</forename><surname>Cuenca-Lopez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Raquel M. Melero-Fernández</forename><surname>De Mera</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elena</forename><surname>Puerta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andonis</forename><surname>Karachitos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Piotr</forename><surname>Bednarczyk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hanna</forename><surname>Kmita</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Norberto</forename><surname>Aguirre</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><forename type="middle">F</forename><surname>Galindo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joaquin</forename><surname>Jordán</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbadis.2010.07.024</idno>
		<idno type="PMID">20691259</idno>
		<ptr type="open-access" target="https://hal.archives-ouvertes.fr/hal-00623299/file/PEER_stage2_10.1016%252Fj.bbadis.2010.07.024.pdf" />
	</analytic>
	<monogr>
		<title level="j">Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</title>
		<title level="j" type="abbrev">Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</title>
		<idno type="ISSN">0925-4439</idno>
		<imprint>
			<biblScope unit="volume">1802</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1036" to="1047" />
			<date type="published" when="2010-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>García-Fuster</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ramos-Miguel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Rivero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>La Harpe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Meana</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>García-Sevilla</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuroscience.2008.09.002</idno>
		<idno type="PMID">18834930</idno>
	</analytic>
	<monogr>
		<title level="j">Neuroscience</title>
		<title level="j" type="abbrev">Neuroscience</title>
		<idno type="ISSN">0306-4522</idno>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="105" to="119" />
			<date type="published" when="2008-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
